immune system
• slightly greater frequency of peritoneal monocytes in LPS-treated mice
|
• in LPS-treated mice
|
• in LPS-treated mice
|
• from macrophages in response to TLR agonists that activate signaling via the Myd88-dependent pathway
• however, response to agonists that activate signaling via the TRIF-dependent pathway is normal
|
• LPS-treated mice exhibit delayed recovery as determined by lower body weight and temperature compared with wild-type mice
|
homeostasis/metabolism
• in LPS-treated mice
|
• in LPS-treated mice
|
• in LPS-treated mice after 18 to 42 hours
|
growth/size/body
• in LPS-treated mice after 18 to 42 hours
|
hematopoietic system
• slightly greater frequency of peritoneal monocytes in LPS-treated mice
|